We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Berkeley Lights Inc (BLI) USD0.00005

Sell:$5.02 Buy:$5.04 Change: $0.41 (8.91%)
NASDAQ:3.33%
Market closed |  Prices as at close on 27 May 2022 | Switch to live prices |
Sell:$5.02
Buy:$5.04
Change: $0.41 (8.91%)
Market closed |  Prices as at close on 27 May 2022 | Switch to live prices |
Sell:$5.02
Buy:$5.04
Change: $0.41 (8.91%)
Market closed |  Prices as at close on 27 May 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Berkeley Lights, Inc. is a digital cell biology company. The Company is focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. The Company's Berkeley Lights Platform captures deep phenotypic, functional, and genotypic information for thousands of single cells in parallel and can also deliver the live biology customers desire in the form of the best cells. Its platform delivers live biology, in the form of cell-based products. It is a fully integrated, end-to-end solution, comprised of proprietary consumables, including OptoSelect chips and reagent kits, advanced automation systems, and advanced application and workflow software. The Company platform proprietary OptoElectro Positioning (OEP) technology, which provides deterministic positioning of living single cells and other micro-objects using light. The Company's software products include Cell Analysis Suite (CAS), Assay Analyzer and Image Analyzer.

Contact details

Address:
5858 Horton Street, Suite 320
EMERYVILLE
94608-2183
United States
Telephone:
+1 (510) 8582855
Website:
www.berkeleylights.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
BLI
ISIN:
US0843101017
Market cap:
$305.22 million
Shares in issue:
67.83 million
Sector:
Life Sciences Tools & Services
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Gregory Lucier
    Executive Chairman of the Board
  • Siddhartha Kadia
    Chief Executive Officer, Director
  • Igor Khandros
    Co-Founder, Independent Director
  • J. Paul Mcclaskey
    Senior Vice President, Chief Accounting Officer
  • Keith Breinlinger
    Chief Technology Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.